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Introduction
Elucidation of the pathogenesis of bone and soft tissue 
tumors has been challenging because the genetic events 
are unique for the different mesenchymal tumor sub-
types. However, enormous progress has been achieved 
with the advancement of cytogenetic and molecular 
genetic techniques. As a result, relevant oncogenes and 
tumor suppressor genes have been identifi ed and local-
ized, and new gene constructs and their protein prod-
ucts that result from translocations during sarcoma 
genesis have been determined. The identifi cation of 
tumor-specifi c genetic markers for bone and soft tissue 
tumors, such as Ewing’s sarcoma, has added a new 
dimension to the formulation of a diagnosis and the 
resolution of cellular origin. Many of the genetic markers 
appear to have prognostic value, and studies to deter-
mine their potential applications as specifi c therapeutic 
targets are in progress. Three common genetic 
approaches used to identify mesenchymal tumor-
specifi c abnormalities are conventional cytogenetic, 
molecular cytogenetic (fl uorescence in situ hybridiza-
tion, or FISH) and reverse transcription-polymerase 
chain reaction (RT-PCR) analyses. In this instructional 
lecture, emphasis is placed on the practical applications 
of each of these techniques, including their advantages 
and limitations. Certain case presentations are included 
to illustrate the integration of traditional histopatho-
logical and genetic approaches and serve as useful 
paradigms.
Genetic approaches commonly used as diagnostic aids
Cytogenetic analysis
Tissue submitted for cytogenetic analysis must be fresh 
(not frozen or fi xed in formalin) because living, dividing 
cells are required. This specimen requirement is dis-
tinctly limiting because for some hospitals, specimens 
are received in the cutting room already fi xed in forma-
lin or the pathologist may prematurely place it in 
formalin. Thus, to use the karyotyping approach, the 
pathologist must plan ahead and submit a viable portion 
of the specimen prior to fi xation. A mesenchymal tumor 
sample submitted for cytogenetic analysis should be 
representative of the neoplastic process and preferably 
be part of the specimen submitted for pathological 
study. Ideally, a 1- to 2-cm3 (approximately 0.5–1.0 g) 
fresh sample is provided for analysis. Also, small biopsy 
specimens or fi ne-needle aspirates (<500 mg) can be 
analyzed successfully (although prolonged culture may 
be needed to produce enough cells for examination).1 
Efforts to perform cytogenetic analysis are worthwhile 
even when material is limited, as the presence of a single 
cell exhibiting a tumor-specifi c chromosomal abnormal-
ity provides strong diagnostic support.
The basic process of cell culturing and karyotypic 
analysis is the same for all mesenchymal neoplasms. 
The length of time that a bone or soft tissue tumor is 
cultured to attain satisfactory karyotypic fi ndings is 
variable, though, and may be dependent on the histo-
pathological type, grade of tumor, tumor cellularity, and 
size of specimen submitted for analysis. A short-term 
culture usually results in a suffi cient number of mitoses 
within 10 days or less. Lengthy culture times should be 
avoided because undesired overgrowth by normal fi bro-
blasts is more likely to occur.
An alternative to tissue culture is direct or same-day 
harvest. With this technique, endemic dividing cells are 
arrested after a 1- to 12-h incubation in colchicine and 
Offprint requests to: J.A. Bridge
Received: November 7, 2007
This Instructional Lecture was presented at the 40th Annual 
Musculoskeletal Tumor Meeting of the Japanese Orthopaedic 
Association, Kofu, July 13, 2007
© 2008 The Japanese Orthopaedic Association. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
274 J.A. Bridge: Genetics of mesenchymal neoplasms
culture medium. This method is useful for obtaining fast 
or preliminary results but is constrained by the in vivo 
mitotic index. Thus, direct harvest may be most useful 
for high-grade tumors. Also, for best success, it is imper-
ative that the laboratory receive the tissue sample within 
1 h after biopsy.
G-banding is the most common form of banding for 
karyotyping. This is attributable to the relative ease of 
performing the technique, the reliability of the results, 
and the permanence of the preparations. G-bands can 
be obtained with Giemsa or Wright stains pretreated 
with trypsin or phosphate buffer, respectively.2–4 The 
number of alternating light and dark bands detectable 
with G-banding in the haploid genome varies with the 
level of chromosomal contraction in each metaphase 
cell, but it is in the range of 350–550 bands per haploid 
set. Because one band represents approximately 5–10 × 
106 base pairs (bp) of DNA5 and therefore could poten-
tially contain hundreds of genes, cytogenetic analysis is 
not considered a high-resolution technique.
Simplistically, chromosomal abnormalities can be 
divided into two major categories: numerical and struc-
tural abnormalities. Numerical abnormalities manifest 
as changes in complete sets of chromosomes [i.e., trip-
loid (3 N) or tetraploid (4 N) complements] or in the 
number of individual chromosomes [i.e., loss of a single 
chromosome (monosomy) or gain of a single chromo-
some (trisomy)]. Structural abnormalities of chromo-
somes result from chromosomal breakage and rejoining 
of the broken ends to form new combinations. A fre-
quently observed structural abnormality in mesen-
chymal neoplasms is translocation. In a reciprocal 
translocation, chromosomal material is exchanged 
between two or more nonhomologous chromosomes. 
An example of the shorthand system used to describe 
numerical and structural aberrations is 47,XY,+8,t(11;
22)(q24;q12), in which 47 indicates the total chromo-
some number, XY indicates the sex constitution, and +8 
indicates an extra copy, trisomy, of chromosome 8. The 
“t” is an abbreviation for translocation and in this 
example specifi es an exchange of chromosomal material 
between the long arms of chromosomes 11 and 22 at 
bands q24 and q12, respectively. (A comprehensive 
compendium of cytogenetic nomenclature can be found 
in the 2005 An International System for Cytogenetic 
Nomenclature.6) The 11;22 translocation is a character-
istic rearrangement in Ewing’s sarcoma, and trisomy 8 
is a frequent secondary anomaly in this neoplasm.7 A 
signifi cant strength of cytogenetic analysis is that it 
provides a global assessment of both numerical and 
structural abnormalities in a single assay, including both 
primary and secondary anomalies. Moreover, in con-
trast to FISH or RT-PCR, knowledge of the anticipated 
anomaly or histological diagnosis is not necessary, as 
illustrated in the following case.
An 88-year-old woman presented with a large (7 cm), pal-
pable, painless lumbar region mass that projected into the 
retroperitoneal space (Fig. 1). A computed tomography 
(CT)-guided needle biopsy was performed. The lesion 
appeared to be composed of stellate- or spindle-shaped cells 
in a relatively dense collagenous stroma, and a diagnostic 
interpretation of desmoid tumor was rendered (Fig. 2). Karyo-
typic studies of desmoid tumors have revealed two cytogenetic 
subgroups: one group characterized by loss or deletion of 
5q21–22 and one group characterized by extra copies of chro-
mosomes 8 and/or 20.8 Chromosomal analysis of the current 
case, however, showed one to three supernumerary ring chro-
mosomes (Fig. 3A). Subsequent FISH studies performed on 
unstained metaphase cells with a chromosome 12 paint probe 
demonstrated that the supernumerary ring chromosomes 
were composed of chromosome 12 material (Fig. 3B). The 
fi nding of supernumerary ring chromosomes composed of 
chromosome 12 material and accompanied by few or no other 
abnormalities is characteristic of well-differentiated liposar-
coma, in particular involving the 12q14–15 region resulting 
in low-level amplifi cation of this chromosomal region and 
the genes mapped within, such as MDM2 (Fig. 3C) and 
CDK4.9,10
Equipped with these unexpected genetic fi ndings, the surgi-
cal pathology slides were retrieved for rereview and on closer 
examination, rare atypical cells were discovered. It was 
thought that this biopsy probably represented a nonlipogenic 
zone in a well-differentiated (sclerosing) liposarcoma. This is 
a recognized pitfall of small-needle biopsies; that is, sampling 
specimens from such areas (nonlipogenic sclerosing areas) can 
lead to an erroneous conclusion that the tumor is not a lipo-
sarcoma.11 Subsequently, the patient’s tumor was resected, 
and lipogenic areas with lipoblasts were detected in addition 
to the highly atypical stromal cells consistent with a diagnosis 
of sclerosing liposarcoma.
This case illustrates the value of cytogenetic analysis 
as a diagnostic aid in the classifi cation of mesenchymal 
neoplasms, particularly in the setting of limited tissue 
Fig. 1. Lumbar region, retroperitoneal mass (arrow)
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that serve as probes. With this approach, specifi c nucleic 
acid sequences can be detected in morphologically 
preserved chromosomes, cells, or tissue sections.
Molecular cytogenetic assays typically are performed 
with chromosome-specifi c probes labeled with fl uores-
cent dyes such as fl uorescein and detected with fl uores-
cence microscopy (FISH). Probe detection or labeling 
with fl uorescent molecules with different excitation and 
emission characteristics allows simultaneous analysis of 
several probes. Alternatively, hybridization signals can 
be detected with peroxidase or alkaline phosphatase, 
but these approaches are generally less sensitive.
A distinct advantage of FISH in contrast to conven-
tional cytogenetic analysis is that this technique can be 
performed on nondividing (interphase) cells from fresh 
or aged samples (e.g., blood smears, touch imprint cyto-
logical preparations, cytospin preparations), paraffi n-
embedded tissue sections, and disaggregated cells 
retrieved from fresh, frozen, or paraffi n-embedded 
material. Importantly, this procedure can provide results 
(e.g., identifi cation of a tumor-specifi c translocation or 
loss of a tumor suppressor gene locus) when the tissue 
is insuffi cient or unsatisfactory for cytogenetic analysis, 
when conventional cytogenetic analysis has failed to 
yield results, or when cryptic rearrangements are 
present.12
Blood smears, touch imprint cytological preparations, 
and cytospin preparations are air-dried and subse-
quently fi xed in methanol–glacial acetic acid (3 : 1) for 
5 min. To visualize an anomaly in a specifi c region of 
a tumor or in a specifi c cell type, a 4- to 6-μm thick 
Fig. 2. Computed tomography (CT)-guided needle biopsy 
specimen exhibiting spindle- and stellate-shaped cells in a 
collagenous background
Fig. 3. A Multiple ring chromosomes 
(arrows) in a G-banded metaphase 
cell of a sclerosing (well-differenti-
ated) liposarcoma. B Ring chromo-
somes (arrows) are composed of 
chromosome 12 material, as demon-
strated by fl uorescence in situ hybrid-
ization (FISH) analysis with a whole 
chromosome 12-paint probe. This 
image is of a partial metaphase 
cell also showing two normal chromo-
some 12 homologues. C Bicolor FISH 
analysis with a chromosome 12 centro-
mere-specifi c probe (green) and 
MDM2 locus-specifi c probe (red) 
demonstrates MDM2 amplifi cation 
in the ring chromosomes (arrows). 
This image is of a partial metaphase 
cell also showing two normal chromo-
some 12 homologues (red and green 
signals)
A
B
C
sampling or misleading histopathological fi ndings. 
Additional advantages and limitations of conventional 
cytogenetic analysis are summarized in Table 1.
Molecular cytogenetics
A revolutionary tool in the analysis and characteriza-
tion of chromosomes and chromosomal abnormalities 
has been the development of in situ hybridization (ISH) 
techniques. Hybridization refers to the binding or 
annealing of complementary DNA or RNA sequences 
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paraffi n-embedded tissue section can be used. Analysis 
of thin sections, however, is limited because portions of 
most nuclei are lost during sectioning, which may lead 
to false-positive results in the evaluation of chromo-
somal deletions or losses. For the most accurate assess-
ment of subtle aneuploidy changes, the preferred 
approach is to obtain whole or intact nuclei by disag-
gregating and releasing cells from a much thicker 
(50–60 μm) section. FISH is a same-day or overnight 
procedure, depending on the probes used or the type of 
specimen analyzed (or both).
Chromosomal probes (complementary DNA 
sequences) frequently used to examine bone and 
soft tissue tumors can be divided into three categories 
(Fig. 4): (1) Centromere-specifi c probes are composed 
of tandemly repeated monomers or α-satellite sequences 
(171 bp) that are unique for each chromosome. These 
probes are useful for chromosome enumeration. (2) 
Single copy probes that are homologous to specifi c 
targets ranging from 15 to more than 500 kilobases (kb) 
in size are referred to as “locus-specifi c” probes. Locus-
specifi c probes are often used for assessing oncogenes 
or tumor suppressor genes. Many tumor-specifi c trans-
locations can be identifi ed with locus-specifi c probes. 
(3) “Paint,” or whole chromosome, probes are com-
prised of probe mixtures with homology at multiple 
sites along the target chromosomes. Interphase cell 
analysis is impractical with whole chromosome probes 
because the decondensed chromosomes are spread over 
too large an area for proper signal interpretation. Whole 
chromosome probes are most useful for characterizing 
structural chromosomal anomalies in metaphase cells.
Conventional karyotyping is limited by its inability to 
identify cryptic abnormalities, complex aberrations, and 
marker chromosomes accurately. To facilitate karyo-
typing — particularly analysis of complex cases with 
multiple chromosomal rearrangements and marker 
chromosomes — universal chromosome painting and 
multicolor banding techniques [e.g., multifl uor-FISH 
(M-FISH), spectral karyotyping (SKY), spectral color 
banding (SCAN)] — have been developed.13–16 These 
approaches are well suited to solid tumors because the 
complexity of the karyotypes may often mask the pres-
ence of recurrent chromosomal aberrations. Consider 
the following case.
An 81-year-old woman presented with a painless mass in the 
proximal anterior right thigh. Six years earlier, the patient had 
Table 1. Advantages and limitations of conventional cytogenetic analysis
Advantages
 Provides global information in a single assay
  Includes primary and secondary anomalies
  Knowledge of anticipated anomaly or histological diagnosis not necessary
 Variants undetectable by interphase FISH or RT-PCR may be uncovered
 Diagnostically useful
  Sensitive and specifi c
  Can be performed on fi ne-needle aspirates
 Provides direction for molecular studies of pathogenetically important genes
Limitations
 Requires fresh tissue
  Although direct preparations can be performed, cell culture is typically required (1–10 days)
  May encounter complex karyotypes with suboptimal morphology
  Submicroscopic or cryptic rearrangements may result in a false-negative result
  Normal karyotypes may be observed following therapy-induced tumor necrosis or overgrowth of normal supporting 
 stromal cells
 Diffi culties encountered with bone tumors include low cell density and the release of cells from bone matrix
FISH, fl uorescence in situ hybridization; RT-PCR, reverse transcription-polymerase chain reaction
= example of whole chromosome (paint) probe
= example of locus-specific probe
= example of centromere-specific probe
Interphase Cell Appearance
centromere-specific probe
centromere and 
locus-specific
probes
Fig. 4. Chromosome probe examples and 
the interphase cell appearance of centro-
mere- and locus-specifi c probes
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a “spindle cell hemangioendothelioma” resected with ade-
quate margins at a site distal to the more recent lesion. Mag-
netic resonance imaging (MRI) of the current lesion indicated 
a large nonhomogeneous mass pushing the femoral vessels 
laterally. A biopsy performed by her local physician was 
interpreted as a “spindle cell sarcoma.” The patient was 
subsequently referred to the University of Nebraska Medical 
Center.
At operation, a 14 × 11 × 10 cm mass was resected in conti-
nuity with the superfi cial inguinal nodes, preserving the 
femoral vessels and nerves. The cut surface of the lobulated, 
fi rm mass was pink-red with focal punctate calcifi cations. His-
topathological examination revealed an admixture of thin-
walled, variably dilated cavernous spaces and cellular zones 
of moderately pleomorphic spindle-shaped cells and rounded 
epithelioid-like cells (Fig. 5). Flattened endothelial cells lined 
the cavernous vessels, some of which contained organized and 
calcifi ed thrombi. Mitoses were rare. The spindle-shaped and 
epithelioid-like cells were immunoreactive for vimentin but 
negative for factor VIII-related antigen, lectin Ulex europaeus 
agglutinin, desmin, muscle-specifi c actin, CD31, CD34, and 
S-100 protein. Focal immunoreactivity for CD31, factor VIII-
related antigen, and lectin UEA-1 was present in the endo-
thelial cells lining the vasculature. A defi nitive diagnosis based 
on the histological and immunohistochemical fi ndings could 
not be rendered even following expert consultation.
A representative portion of the sample submitted for con-
ventional cytogenetic analysis demonstrated the following 
abnormal primary clone: 48,XX,+r1,+r2. In an effort to deter-
mine the composition of the ring chromosomes identifi ed by 
G-banding, M-FISH studies were employed and revealed that 
the larger ring was composed of material from chromosomes 
7 and 16 [der(7)r(7;16)(?p22q33;?p11.2p13.3)], and the smaller 
ring was composed of chromosome 13 [r(13)(?p12q21)] (Fig. 
6A). These fi ndings prompted further FISH investigation 
with locus-specifi c probes to assess for the presence of the 
(7;16)(q33;p11.2) rearrangement or FUS/CREB3L2 fusion. 
Fusion of the FUS and CREB3L2 gene loci, characteristic of 
low-grade fi bromyxoid sarcoma, was identifi ed (Fig. 6B) and 
played a central role in establishing the diagnosis of this clini-
cally unusual (uncommon age) and histopathologically atypi-
cal (foci of epithelioid cytomorphology and cavernous vascular 
spaces) case.
Advantages of FISH as illustrated in this case is that 
it can (1) be informative in both metaphase and inter-
phase cell preparations, the latter to include formalin-
fi xed, paraffi n-embedded tissue; (2) assist in deciphering 
the origin of marker chromosomes, ring chromosomes, 
and cryptic or complex chromosomal rearrangements; 
and (3) reveal tumor-specifi c anomalies that are diag-
nostically useful, especially for classifying mesenchymal 
neoplasms with atypical clinical or histopathological 
features. Similar to other mesenchymal tumor types 
(e.g., Ewing’s sarcoma, peripheral primitive neuroecto-
dermal tumor), the morphological spectrum of low-
grade fi bromyxoid sarcoma has recently expanded 
following genotypic characterization.17,18 A summary of 
advantages and limitations of molecular cytogenetic 
approaches is provided in Table 2.
Reverse transcription-polymerase chain 
reaction analysis
Translocations, or exchange of chromosomal material 
between two or more nonhomologous chromosomes, 
are encountered frequently as tumor-specifi c anomalies 
in mesenchymal neoplasms. These tumor-specifi c trans-
locations serve as important guides for molecular biolo-
gists conducting positional cloning studies of the genes 
at the translocation breakpoints. The most common 
genetic consequence of these translocation events is the 
fusion of two genes, one from each translocation partner, 
resulting in the formation of a chimeric gene. The fusion 
proteins encoded by these chimeric genes are not 
found in normal cells and are frequently tumor-specifi c 
(Table 3).
Table 2. Advantages and limitations of molecular cytogenetic analysis
Advantages
 Can be performed on metaphase or interphase cell preparations (fresh, frozen, or paraffi n-embedded material) 
 Can localize anomaly in specifi c cells or tissue types
 Can provide results when tissue is insuffi cient or unsatisfactory for cytogenetic analysis, when conventional cytogenetics has 
failed to yield results, or when cryptic rearrangements are present
 Diagnostically useful. Sensitive and specifi c
 Rapid turn-around time
Limitations
 More targeted approach; not screening tool (generally requires prior knowledge of anomaly of interest)
  Exceptions are CGH and SKY
 Still a relatively gross approach when contrasting other molecular approaches capable of detecting single base mutations
 Number of commercially available probes is limited
 Requires fl uorescence microscopy (signal fading)
 Interpretation may be challenging when analyzing suboptimal specimens (i.e., background fl uorescence or autofl uorescence, 
particularly with formalin-fi xed, paraffi n-embedded material)
 FISH nomenclature not consistent among laboratories
CGH, comparative genomic hybridization; SKY, spectral karyotyping
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In sarcomas, the fusion genes most often code for 
aberrant transcription factors that result in inhibition of 
normal cellular differentiation, cell cycle activation, and 
loss of responsiveness to extracellular signals. Note that 
new cytogenetic and molecular genetic variants con-
tinue to be defi ned. Cytogenetic variants are defi ned as 
differing chromosomal translocation partners [i.e., 
t(2;17) and t(2;2) in infl ammatory myofi broblastic tumor 
(Fig. 7)]; and molecular variants are often the result of 
genomic breakpoint differences that lead to distinct 
fusion product exon combinations (Fig. 8). For example, 
the two most frequent exon combinations in Ewing’s 
sarcoma-associated EWS/FLI1 fusion transcripts include 
fusion of EWS exon 7 to FLI1 exon 6 (type I) and fusion 
of EWS exon 7 to FLI1 exon 5 (type II). These molecu-
lar variants can be detected by their unique RT-PCR 
product band size. The identity of less common or unex-
pected product band sizes should be confi rmed utilizing 
A B
Fig. 5. A Low-grade fi bromyxoid 
sarcoma (LGFMS) showing a cellu-
lar zone of predominantly rounded 
epithelioid-like cells. B Thin-walled, 
variably dilated cavernous spaces in a 
less cellular background
der(7)r(7;16)
167 13
r(13)
A B
Fig. 6. A Partial multifl uor (M)-FISH 
and inverted 4.6-diamino-2-phenylin-
dole (DAPI) image illustrating 
the chromosomal composition of the 
two supernumerary ring chromosomes. 
B Bicolor FISH with a FUS (16p11) 
spanning probe in Spectrum Green 
and a CREB3L2 (7q33) spanning 
probe in Spectrum Red demonstrates 
fusion of green and red signals (arrows) 
indicative of the t(7;16)(q33;p11) char-
acteristic of low-grade fi bromyxoid 
sarcoma
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additional approaches, such as direct sequencing or 
digestion with specifi c restriction endonucleases.19
The highly specifi c gene rearrangements that result 
from chromosomal translocations in bone and soft tissue 
tumors can be identifi ed with RT-PCR analysis. The 
PCR technique uses specifi c synthetic primers to amplify 
a section of a gene in vitro. PCR can be carried out 
on RNA following reverse transcription (mRNA → 
cDNA). Snap frozen tissue is preferred for RNA extrac-
tion and RT-PCR analysis, but this procedure can also 
be performed on archival (paraffi n-embedded) material 
Table 3. Characteristic and variant chromosomal translocations and associated fusion genes in bone and soft tissue sarcomas
Neoplasm Translocation Fusion gene(s)
Alveolar soft part sarcomaa der(17)t(X;17)(p11.2;q25.3) ASPL/TFE3
Alveolar rhabdomyosarcoma t(2;13)(q35;q14)
t(1;13)(p36;q14)
t(X;2)(q13;q35)
t(2;2)(q35;p23)
PAX3/FOXO1b
PAX7/FOXO1
PAX3/AFX
PAX3/NCOA1
Angiomatoid fi brous histiocytoma t(2;22)(q34;q12)
t(12;22)(q13;q12)
t(12;16)(q13;p11)
EWS/CREB1
EWS/ATF1
FUS/ATF1
Clear cell sarcoma t(12;22)(q13;q12)
t(2;22)(q34;q12)
EWS/ATF1
EWS/CREB1
Congenital fi brosarcoma t(12;15)(p13;q25) ETV6/NTRK3
Dermatofi brosarcoma protuberans t(17;22)(q22;q13) COL1A1/PDGFB
Desmoplastic small round cell tumor t(11;22)(p13;q12) EWS/WT1
Epithelioid hemangioendothelioma t(1;3)(p36;q25) ?
Ewing sarcoma/pPNET t(11;22)(q24;q12)
t(21;22)(q22;q12)
t(7;22)(q22;q12)
t(17;22)(q21;q12)
t(2;22)(q33;q12)
inv(22)(q12q12)
t(16;21)(p11;q22)
EWS/FLI1
EWS/ERG
EWS/ETV1
EWS/EIAF
EWS/FEV
EWS/ZSG
FUS/ERG
Extraskeletal myxoid chondrosarcoma t(9;22)(q22;q12)
t(9;17)(q22;q11)
t(9;15)(q22;q21)
t(3;9)(q11–12;q22)
EWS/NR4A3c
RBP56d/NR4A3c
TCF12/NR4A3c
TFG/NR4A3c
Infl ammatory myofi broblastic tumor t(1;2)(q22;p23)
t(2;19)(p23;p13)
t(2;17)(p23;q23)
t(2;2)(p23;q13)
TPM3/ALK
TPM4/ALK
CLTC/ALK
RANBP2/ALK
Low-grade fi bromyxoid sarcoma t(7;16)(q33;p11) 
t(11;16)(p11;p11)
FUSe/ CREB3L2
FUS/CREB3L1
Myxoid/round cell liposarcoma t(12;16)(q13;p11)
t(12;22)(q13;q12)
FUS
e
/CHOPf
EWS/CHOPf
Pericytoma t(7;12)(p22;q13) AGTB/GLI
Synovial sarcoma t(X;18)(p11.2;q11.2)
t(X;20)(p11.2;q13.3)
SS18g/SSX1
SS18/SSX2
SS18/SSX4
SS18L1/SSX1
pPNET, peripheral primitive neuroectodermal tumor
a A balanced form of this translocation is seen also in a subset of pediatric renal neoplasms
b Also referred to as FKHR
c Also referred to as TEC, MINOR, CHN, and NOR-1
d Also referred to as TAF2N
e Also referred to as TLS
f Also referred to as DDIT3
g Also referred to as SYT
if the RNA is of suffi cient quality, as illustrated in the 
following case.
A 39 year-old-man presented with an intermittently painful 
swelling on the ulnar aspect of his right wrist. He also com-
plained of occasional numbness and tingling in the hand. T2-
weighted MRI demonstrated an enhancing lesion originating 
at the distal radioulnar joint and extending across the wrist in 
the volar aspect deep to the fl exor tendon. An open biopsy of 
the lesion revealed a monomorphic population of spindle cells 
arranged in interlacing fascicles and sheets (Fig. 9). The neo-
plastic cells were focally immunoreactive for epithelial mem-
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brane antigen and S-100 protein and negative for MAK6 
(cytokeratin). Consequent RT-PCR studies performed on the 
formalin-fi xed, paraffi n-embedded biopsy specimen revealed 
the presence of an SS18/SSX2 fusion transcript, thereby con-
fi rming the favored diagnosis of monophasic synovial sarcoma 
(Fig. 10). Subsequently, a below-elbow amputation was per-
formed (Fig. 11). Monophasic spindle cell synovial sarcoma 
may be confused with, or misdiagnosed as, fi brosarcoma, leio-
myosarcoma, malignant peripheral nerve sheath tumor, or 
hemangiopericytoma. Identifi cation of the synovial sarcoma-
specifi c X;18 translocation and/or its associated fusion tran-
scripts (SS18/SSX1 or SS18/SSX2) is useful for establishing 
the diagnosis.
RT-PCR analysis is remarkably sensitive. It may 
allow detection of abnormalities present in cells too few 
to be identifi ed with traditional cytogenetic or FISH 
methods. It may be suitable for the detection or moni-
toring of minimal residual disease. Also, RT-PCR anal-
ysis is not dependent on successful cell culture; and, 
similar to FISH, it is rapid, with a short turnaround 
time. Compared with cytogenetic analysis, the greatest 
disadvantage of RT-PCR analysis is the inability to 
detect chromosomal anomalies other than those for 
which the test was designed. With conventional cytoge-
netic analysis, all major chromosomal abnormalities, 
t(2;2)(p23;q13) t(2;17)(p23;q23)
A B
Fig. 7. A, B Two examples of cytoge-
netic variant translocations in infl am-
matory myofi broblastic tumor
7     4     5     6    7     8     9
EWS                    FLI1
Patient Sample, Lane 1
Pos. Control, Lane 2
M        1         2         3        M
7    5     6     7     8     9
M = 100 bp marker
1 = pt. sample
2 = pos. control
3 = neg. control
Fig. 8. Ethidium-stained gel of reverse 
transcriptase-polymerase chain reaction 
(RT-PCR) results for a patient with sus-
pected Ewing’s sarcoma. Total RNA was 
extracted from frozen tumor tissue and 
subjected to RT-PCR. M, DNA molecu-
lar weight marker (100-bp ladder); lane 1, 
patient sample with molecular variant 
fusion transcript 540 bp; lane 2, type II 
fusion transcript positive control 324 bp; 
lane 3, negative no template control
J.A. Bridge: Genetics of mesenchymal neoplasms 281
Fig. 9. Neoplasm composed of vague fascicles of uniform, 
spindle-shaped cells with ovoid, pale-staining nuclei. Inset 
Neoplastic cells are immunohistochemically negative for 
MAK6 (cytokeratin)
M    1     2     3     4     M    5     6     7     8
including those not initially anticipated by the clinician 
or the laboratory staff may be uncovered. Additional 
advantages and limitations of RT-PCR analysis are 
listed in Table 4.
Conclusion
Dramatic advances in cytogenetic and molecular bio-
logical techniques have furthered our understanding 
of sarcomagenesis. Cytogenetic and molecular genetic 
assays are used routinely for diagnostic and prognostic 
purposes in molecular pathology laboratories and 
represent a powerful adjunct to conventional micros-
copy and radiographic assessment for formulating 
an accurate diagnosis.20 Care should be taken, however, 
to recognize the limitations of these approaches. 
Ideally, more than one technical approach should be 
available to a diagnostic laboratory to compensate for 
Fig. 10. Ethidium-stained gel of RT-PCR 
results for a patient with suspected syno-
vial sarcoma. Total RNA was extracted 
from formalin-fi xed, paraffi n-embedded 
tissue and subjected to RT-PCR. M, A 
DNA molecular weight marker (100-bp 
ladder); lanes 1 and 2, patient sample run 
in duplicate is negative for a SS18/SSX1 
fusion transcript; lane 3, SS18/SSX1 fusion 
transcript 110-bp positive control; lanes 4 
and 8, negative no template control; lanes 
5 and 6, patient sample run in duplicate is 
positive for a 110-bp SS18/SSX2 fusion 
transcript; lane 7, SS18/SSX2 fusion tran-
script 200-bp variant positive control
Fig. 11. Flesh-toned synovial sarcoma 
mass measuring 4.4 cm in greatest dimen-
sion was deep to the fl exor muscles and 
advanced along the intermuscular planes 
proximally
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Table 4. RT-PCR analysis
Advantages
 Can be performed on fresh, frozen, or paraffi n-embedded material
  Tissue quantity requirement is small
  Can provide results when tissue is insuffi cient or unsatisfactory for cytogenetic analysis, when conventional cytogenetics has 
failed to yield results, or when cryptic rearrangements are present
 Diagnostically useful
  Sensitive and specifi c
  Rapid turn-around time
  Because of its remarkable sensitivity, RT-PCR may be useful for detecting minimal residual disease or early relapsed 
disease
Limitations
 Not all sarcomas exhibit characteristic fusion gene transcripts
 Targeted approach; not a screening tool 
  Requires prior knowledge of fusion transcript
  RNA quality may be inadequate secondary to RNA degradation
  Reagent contamination is a potential hazard in small laboratories
  Devised primer sets may not detect unusual molecular variants (false negative)
   Identifi cation of some product bands may require validation by additional approaches such as direct sequencing, transfer 
and hybridization with internal oligonucleotide probes, digestion with specifi c restriction endonucleases, or 
reamplifi cation with internal primers (nested RT-PCR)
the shortcomings of another in different clinical 
situations.
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